Insulin-like growth factor replacement therapy for diabetic neuropathy: experimental basis.
Ishii
Douglas N
DN
Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523, USA. dnishii@aurogen.com
Lupien
Sean B
SB
D000818:Animals; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D018450:Disease Progression; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D009414:Nerve Growth Factors / Q000378:metabolism; D013002:Somatomedins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D009414:Nerve Growth Factors; D013002:Somatomedins; D005947:Glucose